Aaron Berg
Vermogen: 25 M $ op 31-05-2026
Vermogen: 25 M $ op 31-05-2026
Aaron D.
Berg currently serves as President, Chief Executive Officer & Director at Amarin Corp.
Plc since 2024 and holds a Director position at the American Heart Association, Inc. Formerly, Mr. Berg was President, Chief Executive Officer & Director at Essentialis, Inc. from 2009 to 2012.
Other previous roles include Principal at Bristol Myers Squibb Co., Vice President-Marketing at Oscient Pharmaceuticals Corp., Principal at Schering-Plough Corp., Vice President-Marketing at KOS Pharmaceuticals, Inc. from 2001 to 2015, and Principal at GlaxoSmithKline, Inc. Education includes undergraduate studies at the University of Maryland.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-03-2026 | 1.651.900 ( 0,4% ) | 24 M $ | 31-05-2026 | |
| 31-01-2025 | 44.077 ( 0,21% ) | 638 676 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AMARIN CORPORATION PLC | Algemeen Directeur | 04-06-2024 |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Directeur/Bestuurslid | 28-07-2011 |
| Bedrijven | Functie | Einde |
|---|---|---|
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Algemeen Directeur | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Verkoop & Marketing | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau